Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis b
Phenotype C0019204|hepatocellular carcinoma
Sentences 150
PubMedID- 24312130 To investigate whether killer cell immunoglobulin-like receptor (kir) and human leukocyte antigen (hla) genetic background could influence the onset age of hepatocellular carcinoma (hcc) in patients with hepatitis b virus (hbv) infection, one hundred and seventy-one males with hbv-related hcc were enrolled.
PubMedID- 24633222 hepatitis b viral infection-induced hepatocellular carcinoma is one of the major problems in the developing countries.
PubMedID- 26264553 Circulating micrornas as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis b virus.
PubMedID- 26421022 Risk factors for intrahepatic recurrence after resection of hepatocellular carcinomas in patients with hepatitis b virus infection.
PubMedID- 22444598 Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis b infection.
PubMedID- 25133046 Prevention of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 20594228 Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis b virus related cirrhosis.
PubMedID- 24570913 Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 26379440 The hepatitis b virus reactivation after transarterial chemoembolization in chinese hepatocellular carcinoma patients with low serum hepatitis b virus dna level.
PubMedID- 25442807 An adolescent female having hepatocellular carcinoma associated with hepatitis b virus genotype h with a deletion mutation in the pre-s2 region.
PubMedID- 24798001 Whole exome sequencing and copy number analysis was performed on 231 hepatocellular carcinomas (72% with hepatitis b viral infection) that were classified as early-stage hepatocellular carcinomas, candidates for surgical resection.
PubMedID- 20549250 Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis b virus-related liver disease.
PubMedID- 26357607 Data from the long-term follow-up of patients enrolled in the registration studies showed that treatment with entecavir can lead to significant improvements in liver histopathology, and recent cohort studies have demonstrated that treatment with entecavir may reduce disease progression and the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b.
PubMedID- 25269529 High levels of hepatitis b surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis b viral loads.
PubMedID- 22231575 Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis b virus infection.
PubMedID- 23326737 Fatal hepatocellular carcinoma in a patient with occult hepatitis b virus infection following the administration of r-chop for diffuse large b-cell lymphoma.
PubMedID- 24614696 Alpha-fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis b selected for liver transplantation.
PubMedID- 23586065 Aim: to evaluate the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection.
PubMedID- 24393929 A 61-year-old man who complained of right hypochondralgia was diagnosed as hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv) infection.
PubMedID- 25983748 The role of tlr3 in hepatocellular carcinoma (hcc) with hepatitis b virus (hbv) infections is not well understood.
PubMedID- 24930484 Here, we assessed the prognostic performance of lsps in predicting the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb).
PubMedID- 21160979 Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 24187458 Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis b.
PubMedID- 20924214 Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis b virus-related cirrhosis: a cross-sectional case-control study.
PubMedID- 24745029 We evaluated clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-b non-c (nbnc) hepatocellular carcinoma (hcc) patients with comparison to hepatitis b or c virus, paying attention to relationship between alcohol consumption and histopathological findings.
PubMedID- 21480326 Few studies have evaluated the risk of cancers other than hepatocellular carcinoma associated with hepatitis b virus (hbv) infection.
PubMedID- 26380927 The aim of this study was to investigate the feasibility of using serum exosomal micrornas as novel serological biomarkers for hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb).
PubMedID- 21459723 Gpc3 fused to an alpha epitope of hbsag acts as an immune target against hepatocellular carcinoma associated with hepatitis b virus.
PubMedID- 22654459 He was diagnosed with hepatocellular carcinoma (hcc) arising from decompensated hepatitis b virus (hbv)-related cirrhosis.
PubMedID- 25616940 Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis b virus.
PubMedID- 19950233 Hbx is often expressed from the gene integrated in the hepatocytes infected persistently and contributes significantly to alterations in host gene expression that can lead to the development of hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv).
PubMedID- 25735064 A 65-year-old woman had previously undergone ldlt for hepatocellular carcinoma associated with hepatitis b virus infection.
PubMedID- 24344773 Combinations of eight key mutations in the x/prec region and genomic activity of hepatitis b virus are associated with hepatocellular carcinoma.
PubMedID- 26512974 Background: hepatitis b viral infection-induced hepatocellular carcinoma (hcc) is a major threat to human health in china.
PubMedID- 25312649 The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis b on long-term nucleos(t)ide analogue therapy.
PubMedID- 25015850 Case report: we have reported a patient who developed de novo uc after olt to treat liver cirrhosis and hepatocellular carcinoma associated with hepatitis b virus (hbv) infection.
PubMedID- 21170112 [small hepatocellular carcinoma in patients with hepatitis b-induced cirrhosis: a comparison between mri and mdct].
PubMedID- 24440974 Selection of reference genes for rt-qpcr analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis b infection and cirrhosis.
PubMedID- 20738778 Increased pd-1 and decreased cd28 expression in chronic hepatitis b patients with advanced hepatocellular carcinoma.
PubMedID- 23200676 hepatocellular carcinoma (hcc) is associated with hepatitis b virus (hbv) chronicity and dietary exposure to aflatoxin, a mutagen targeting codon 249 of tumor suppressor tp53 (r249s mutation).
PubMedID- 20652159 Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis b virus-related cirrhosis.
PubMedID- 20095888 Objective: to determine the risk factors for the occurrence of hepatocellular carcinoma (hcc) in patients with hepatitis b virus (hbv) infection.
PubMedID- 21548981 hepatocellular carcinoma is mainly associated with viral hepatitis b and c.
PubMedID- 22271485 Statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection.
PubMedID- 24704525 Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis b: a nationwide cohort study.
PubMedID- 24148650 Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis b and minimally fibrotic liver.
PubMedID- 24485003 Thus, the present study was designed to investigate the protective effect of s-adenosylmethionine (same) on hiri, especially for patients with hepatocellular carcinoma (hcc) associated with chronic hepatitis b virus (hbv) infection and cirrhosis.
PubMedID- 20166172 Incidence of hepatocellular carcinoma in patients with chronic hepatitis b virus infection who have normal alanine aminotransferase values.
PubMedID- 22338215 [to investigate the relationship of alcohol intake and hepatocellular carcinoma among patients with hepatitis b virus infection].
PubMedID- 24876745 Several studies have been carried out to create risk calculators for the prediction of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb).

Page: 1 2 3